Tag

FDA approval

Illustration of the larynx seen from above, showing the vocal cords, epiglottis and trachea

FDA clears first DNA immunotherapy for rare airway disease RRP

Voceryq won accelerated approval after a trial of 32 adults in which about a quarter needed no surgery for their papillomas in the following year.

30 October 2026

Drug Approvals

Prostate cancer pill pair approved earlier for DNA repair genes

The FDA has cleared talazoparib with enzalutamide for gene-mutated hormone-sensitive prostate cancer after TALAPRO-3 cut the risk of scan progression or death by 52%.

26 October 2026

Drug Approvals

FDA approves hepatitis B drug that lets some patients stop pills

Hibsago, an antisense injection from GSK, gave about one in five eligible adults a functional cure in two phase 3 trials, against none on placebo.

20 October 2026

Illustration of the large bowel and rectum with a tumour growing in the bowel wall

Drug Approvals

FDA approves immunotherapy that can spare rectal cancer surgery

Jemperli won accelerated approval for dMMR or MSI-H stage II and III rectal cancer after most AZUR-1 patients needed no chemotherapy, radiotherapy or surgery.

19 October 2026